FDA cracks down on weight-loss drug alternatives as thousands sickened in Maryland – Baltimore Sun

FDA cracks down on weight-loss drug alternatives as thousands sickened in Maryland  Baltimore SunGLP-1 wars: Wegovy maker challenges knock-off weight loss drug companies  USA TodayHow FDA’s Action Against Non-FDA-Approved GLP-1 Products Affects the Competitive Landscape  Pharmaceutical Executive2026-02-22 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Shareholders to Learn More About the Investigation | NYSE:HIMS | Press Release  StockhouseHims & Hers Misleads With GLP-1 Claims In Ads, Court Told  Law360